•  
  •  
 

Abstract

Introduction. Incidence of invasive fungal infections (IFI) are reportedly increasing in many countries. Candida is the most common cause of IFI. This study was conducted to determine the prevalence, clinical characteristics, and etiologic pathogen in adult patients with invasive candidiasis (IC) at Cipto Mangunkusumo Hhospital. Methods. This was a cross sectional study with restropective data collection fromof septic patients that’ medical records hospitalized in January 2012 until June 2014. Subjects were selected based on EORTC/MSG 2008 diagnostic criteria for IC. Demographic data, clinical and supporting data, diagnosis, etiologic pathogens, antibiotics, antifungal, outcome, and length of stay were recorded. Results. The IC prevalence at Cipto Mangunkusumo hospital was 12,3% (91 patients from total of 738 sepsis patients). Subjects consisted of 35 proven, 31 probable, and 25 possible invasive candidiasis patients. Candidemia was the most common form of IC and C. albicans was the most common etiologic pathogen. Mean age were 47,9 years, dominated with medical, non-neutropenic, and septic shock patient. Most patients had malignancy with lung infection. The most common medical intervention was urinary catheter. Most patients were given 3rd generation cephalosporin and the most common antifungal used was fluconazole. Forty four percent of IC patients did not get systemic antifungal treatment. Mortality rate was 64.8% and median length of stay were 27 days. Conclusions. IC prevalence was 12,3%. Mortality due to IC was high and C. albicans was the most common etiologic pathogen.

References

1. Hermsen ED, Njoku J, Pfeifer R, Schooneveld TV. The Nebraska medical center guidelines for management of invasive candidiasis. Nebraska: The Nebraska Medical Center Clarkson and University Hospital; 2010. 2. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med. 2006;34:857–63. 3. Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G. Invasive fungal infections in the icu: how to approach, how to treat. Molecules. 2014;19:1085-119. 4. Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, dkk.National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol. 2011;49:325-34. 5. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54. 6. Sahni V, Agarwal SK, Singh NP, Anurada S, Sikdar S, Wadhwa A, Kaur R. Kandidemia: an under-recognized nosocomial infection in indian hospitals. JAPI. 2005;53:607-11. 7. Arora D, Anand N, Goya G, Kumar R, Gupta P, Sarita. Prevalence and risk factor of kandida in cases of kandidemia in a tertiary care hospital. Int J Pharm Pharm Sci. 2011;3:157-9. 8. Leroy O, Gangneux JP, Montravers, P, Mira JP, Gouin F, Sollet JP, dkk. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med. 2009;37:1612-8. 9. Hermsen ED, Zapapas MK, Maiefski M, Rupp ME, Freifeld AG, Kalil AC. Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case- control study. Critical Care. 2011;15:198. 10. Wijayanto D, Amir I, Wahyuningsh R, Windiastuti E. Prevalens dan sebaran faktor risiko mikosis sistemik pada neonatus dengan sepsis awitan lambat di RSCM [Tesis]. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2009. 11. Pauw BD, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, dkk. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/ invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46:1813–21. 12. Molina FJG, Leon C, Ruiz-Santana S, Saavedra P.Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis. Crit Care. 2012;16:105. 13. Leroy G, Lambiotte F, Thevenin D, Lemaire C, Parmentiers E, Devos P, dkk. Evaluation of “Candida score” in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care. 2011;1:50. 14. Morrel M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49:3640-5. 15. Eggimann, Bille J, Marchetti O. Diagnosis of invasive kandidiasis in the ICU. Ann Intensive Care. 2011;1:37. 16. Xie GH, Fang XM, Fang Q, Wu XM, Jin YH, Wang JL, dkk. Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients. Crit Care. 2008;12:5. 17. Singh G, Urhekar AD. Candidal infection: epidemiology, pathogenesis and recent advances for diagnosis. A Peer Rev Int J. 2013;1:1. 18. Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, dkk. Epidemiology of kandidemia in latin america: a laboratory-based survey. PLoS One. 2013;8:e59373. 19. Colombo AL, Nucci M, Park BJ, Nouer SA, Arthington-Skaggs B, da Matta DA, dkk. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44:2816-23. 20. Flanagan P. Clinical diagnosis of fungal infections in the intensive care unit. Dalam: Barnes RA, Warnock WD, penyunting. Fungal infections in the intensive care unit. Massachusetts: Kluwer Academis Publisher; 2002. h105-28. 21. Zarrin M, Mahmoudabadi AZ. Invasive kandidiasis in review article. Jundishapur J Microbiol. 2009;2:1-6. 22. Wahyuningsih R, Rozalyani A, El Jannah SM, Amir I, Prihartono J. Kandidemia pada neonatus yang mengalami kegagalan terapi antibiotik. Maj Kedokt Indon. 2008;58:110-5. 23. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, dkk. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide study. Clin Infect Dis. 2004;39:309-17.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.